Characteristics of individuals who received a complete, 2-dose mpox vaccine regimen as part of the public health response to the mpox epidemic in Ontario, Canada.
Saved in:
| Title: | Characteristics of individuals who received a complete, 2-dose mpox vaccine regimen as part of the public health response to the mpox epidemic in Ontario, Canada. |
|---|---|
| Authors: | Grewal R; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Populations and Public Health, ICES, Toronto, Ontario, Canada., Lau C; Populations and Public Health, ICES, Toronto, Ontario, Canada., Kwong JC; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Populations and Public Health, ICES, Toronto, Ontario, Canada.; Communicable Disease Control, Public Health Ontario, Toronto, Ontario, Canada.; Department of Family and Community Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; University Health Network, Toronto, Ontario, Canada., Burchell AN; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Populations and Public Health, ICES, Toronto, Ontario, Canada.; Department of Family and Community Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, Unity Health Toronto, Toronto, Ontario, Canada., Friedman L; Communicable Disease Control, Public Health Ontario, Toronto, Ontario, Canada., Navarro C; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Communicable Disease Control, Public Health Ontario, Toronto, Ontario, Canada., Okpokoro E; International Research Centre of Excellence, Institute of Human Virology Nigeria, Abuja, Nigeria., Tan DHS; Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, Unity Health Toronto, Toronto, Ontario, Canada.; Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.; Division of Infectious Diseases, St. Michael's Hospital, Toronto, Ontario, Canada., Zygmunt A; Communicable Disease Control, Public Health Ontario, Toronto, Ontario, Canada.; Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada., Bai L; Populations and Public Health, ICES, Toronto, Ontario, Canada., Mishra S; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Populations and Public Health, ICES, Toronto, Ontario, Canada.; Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, Unity Health Toronto, Toronto, Ontario, Canada.; Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.; Division of Infectious Diseases, St. Michael's Hospital, Toronto, Ontario, Canada., Buchan SA; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Populations and Public Health, ICES, Toronto, Ontario, Canada.; Communicable Disease Control, Public Health Ontario, Toronto, Ontario, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada. |
| Corporate Authors: | Canadian Immunization Research Network (CIRN) Investigators |
| Source: | PLOS global public health [PLOS Glob Public Health] 2025 Nov 26; Vol. 5 (11), pp. e0005452. Date of Electronic Publication: 2025 Nov 26 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 9918283779606676 Publication Model: eCollection Cited Medium: Internet ISSN: 2767-3375 (Electronic) Linking ISSN: 27673375 NLM ISO Abbreviation: PLOS Glob Public Health Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41296795 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Characteristics of individuals who received a complete, 2-dose mpox vaccine regimen as part of the public health response to the mpox epidemic in Ontario, Canada. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Grewal+R%22">Grewal R</searchLink>; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Populations and Public Health, ICES, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Lau+C%22">Lau C</searchLink>; Populations and Public Health, ICES, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Kwong+JC%22">Kwong JC</searchLink>; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Populations and Public Health, ICES, Toronto, Ontario, Canada.; Communicable Disease Control, Public Health Ontario, Toronto, Ontario, Canada.; Department of Family and Community Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; University Health Network, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Burchell+AN%22">Burchell AN</searchLink>; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Populations and Public Health, ICES, Toronto, Ontario, Canada.; Department of Family and Community Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, Unity Health Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Friedman+L%22">Friedman L</searchLink>; Communicable Disease Control, Public Health Ontario, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Navarro+C%22">Navarro C</searchLink>; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Communicable Disease Control, Public Health Ontario, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Okpokoro+E%22">Okpokoro E</searchLink>; International Research Centre of Excellence, Institute of Human Virology Nigeria, Abuja, Nigeria.<br /><searchLink fieldCode="AU" term="%22Tan+DHS%22">Tan DHS</searchLink>; Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, Unity Health Toronto, Toronto, Ontario, Canada.; Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.; Division of Infectious Diseases, St. Michael's Hospital, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Zygmunt+A%22">Zygmunt A</searchLink>; Communicable Disease Control, Public Health Ontario, Toronto, Ontario, Canada.; Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Bai+L%22">Bai L</searchLink>; Populations and Public Health, ICES, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Mishra+S%22">Mishra S</searchLink>; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Populations and Public Health, ICES, Toronto, Ontario, Canada.; Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, Unity Health Toronto, Toronto, Ontario, Canada.; Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.; Division of Infectious Diseases, St. Michael's Hospital, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Buchan+SA%22">Buchan SA</searchLink>; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Populations and Public Health, ICES, Toronto, Ontario, Canada.; Communicable Disease Control, Public Health Ontario, Toronto, Ontario, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Canadian+Immunization+Research+Network+%28CIRN%29+Investigators%22">Canadian Immunization Research Network (CIRN) Investigators</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918283779606676%22">PLOS global public health</searchLink> [PLOS Glob Public Health] 2025 Nov 26; Vol. 5 (11), pp. e0005452. <i>Date of Electronic Publication: </i>2025 Nov 26 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918283779606676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2767-3375 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227673375%22">27673375 </searchLink><i>NLM ISO Abbreviation: </i>PLOS Glob Public Health <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41296795 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pgph.0005452 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0005452 Titles: – TitleFull: Characteristics of individuals who received a complete, 2-dose mpox vaccine regimen as part of the public health response to the mpox epidemic in Ontario, Canada. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Grewal R – PersonEntity: Name: NameFull: Lau C – PersonEntity: Name: NameFull: Kwong JC – PersonEntity: Name: NameFull: Burchell AN – PersonEntity: Name: NameFull: Friedman L – PersonEntity: Name: NameFull: Navarro C – PersonEntity: Name: NameFull: Okpokoro E – PersonEntity: Name: NameFull: Tan DHS – PersonEntity: Name: NameFull: Zygmunt A – PersonEntity: Name: NameFull: Bai L – PersonEntity: Name: NameFull: Mishra S – PersonEntity: Name: NameFull: Buchan SA IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 11 Text: 2025 Nov 26 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2767-3375 Numbering: – Type: volume Value: 5 – Type: issue Value: 11 Titles: – TitleFull: PLOS global public health Type: main |
| ResultId | 1 |